Agha Mirza serves as CME Group’s Managing Director and Global Head of Rates and OTC Products. He is responsible for leading CME Group’s Rates and OTC business strategy globally, including growing volume and revenue through client-driven new product development, product extensions and electronic trading optimization.
Mirza has served on the Federal Reserve Board’s Alternative Reference Rates Committee since 2015 and on the Interest Rate Benchmark Reform Subcommittee of the U.S. Commodity Futures Trading Commission’s Market Risk Advisory Committee since 2018.
Before joining the company in 2013, Mirza served as Managing Director and Head of the Canadian Rates business at Citigroup, where he spent 17 years as an interest rates trader and trading manager.
Mirza has taught the MBA class “Rethinking Risk Management” at Insead Business School. He holds both a Master of Science degree and a Bachelor of Science degree from MIT.